focus -WSS

focus

author：knowledge 2025-09-30 17:28:35 - browse：5

Janet Woodcock -- health policy coverage from STAT — Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images

WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s drawn the battle plans for the agency’s next chapter.

Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of therapies and several clashes with Congress and patient advocates. In recent years, she also warded off attacks on the agency’s decisionmaking during the Covid-19 pandemic, particularly when the agency veteran took the acting commissioner role during President Biden’s long search for a permanent leader, and took charge of a vast reorganization plan sparked by the baby formula crisis.

Some of those efforts still hang in the balance as she departs this week. Critics argue that under her oversight, the drug division worked too closely with pharmaceutical companies to give broad approvals to new medicines like Biogen’s Aduhelm or so-called accelerated approval to controversial therapies like Sarepta’s Duchenne muscular dystrophy medicine Exondys 51, which is still in the midst of post-marketing studies to prove its effectiveness.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Amylyx ALS drug fails large clinical trial

WSS

New menopause drug shows promise in relief for hot flashes

The drug industry has found itself all alone in Washington

RSV shot was 90% effective at preventing hospitalizations in kids

The SUPPORT Act is critical to fighting the opioid crisis

JPM 2024: Verve Therapeutics looks to mainstream genome editing

New England Journal of Medicine addresses racist history, slavery

explore

focus

knowledge

Continuity nursing helped my family in our darkest PICU moments

The SUPPORT Act is critical to fighting the opioid crisis

New air purifier tech could be key to improving indoor air quality

Designating disabled people as health disparity population is crucial

In Memoriam: Notable people who died in 2023

NEJM study link tiny plastics in blood vessels to heart problems

Bright Health sells Medicare Advantage business to Molina

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Wildfire smoke exposes gaps in outdoor worker protections

Health and fitness trackers are measuring the wrong things

Wikipedia

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Risky weight loss products often used by teens globally, per study

First medicine developed to treat MASH expected to be approved soon

UnitedHealth quietly bought dozens of outpatient centers

UnitedHealth quietly bought dozens of outpatient centers

Health and fitness trackers are measuring the wrong things

entertainment

focus

knowledge

Wikipedia